Rubicon Research Share Price

    637.45
    -2.75 (-0.43%)
    RUBICON • 02 Dec, 2025 | 01:29 PM
    Buy
    with MTF at2.50xleverage
    The current prices are delayed, login or Open Demat Account for live prices.

    Rubicon Research Stock Performance

    1W Return-2.65
    1Y Return0.00
    Today's Low630.2
    Prev. Close640.20
    Mkt Cap (Cr.)10,502.01
    1M Return3.12
    3Y Return0.00
    52-Week High754.8
    Open640.60
    PE Ratio62.84
    6M Return0.00
    Today's High650
    52-Week Low570.75
    Face Value1

    Rubicon Research Company background

    Founded in: 1999
    Managing director: PRATIBHA SUDHIR PILGAONKAR
    Rubicon Research Limited was incorporated on May 6, 1999, as a Private Limited Company under the name Rubicon Consultants Private Limited, issued by the RoC. Subsequently, the Company name was changed from Rubicon Consultants Private Limited to RubiconResearch Private Limited consequent to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002. The Companys status converted from a Private Limited Company to a Public Limited Company, the name was changed from Rubicon Research Private Limited to Rubicon Research Limited. A fresh Certificate of Incorporation dated July 23, 2024 was issued bythe Registrar of Companies, Central Processing Centre, Manesar, Haryana consequent to Companys conversion into a Public Limited Company.Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. The Company is driven by innovation through focused research and development, with an increasing portfolio of specialty products and drugdevice combination products targeting regulated markets, particularly, the United States. It has obtained its GMP manufacturing facilities at Ambernath and Satara in Maharashtra.The Company commenced manufacturing of certain special drugs in Ambernath Manufacturing Facility in 2011. In 2016, the Company acquired majority stake by ECP III Pte Ltd. Further, it acquired majority stake by General Atlantic Singapore RR Pte. Ltd., from ECP III Pte. Ltd. in 2019. In 2021, the Company acquired the business of Meditab Specialities Limited on slump sale as a going concern. In 2024, the Company acquired Validus, a New Jersey headquartered marketer of brand name formulation products in the US. Validus has twobrand name products in the CNS therapy area (Equetro and Marplan). The Company is planning to raise money from public through IPO aggregating to Rs 1085 Crores, consisting Rs 500 Crore Fresh Issue Equity Shares and an Offer for Sale of Rs 585 Crore Equity Shares.

    Rubicon Research Financial Highlights


    Rubicon Research reported a Q2 FY 2025-26 revenue of ₹412.02 crore, up 48.6% YoY, with net profit increased 47.6% to ₹53.85 crore. For the full year FY2025–2026, revenue reached ₹1296.22 crore and profit touched at ₹134.36 crore.

    Rubicon Research Share Price Today


    As of 3 Dec 2025, Rubicon Research share price is ₹637.4. The stock opened at ₹640.6 and had closed at ₹640.2 the previous day. During today’s trading session, Rubicon Research share price moved between ₹630.20 and ₹650.00, with an average price for the day of ₹640.10. Over the last 52 weeks, the stock has recorded a low of ₹570.75 and a high of ₹754.80. In terms of performance, Rubicon Research share price has increased by 31.4% over the past six months and has declined by 0% over the last year.
    Read More
    View details of Market Depth

    Rubicon Research Fundamental

    Market Cap (in crs)

    10,502.01

    Face Value

    1

    Turnover (in lacs)

    785.80

    Key Metrics

    Qtr Change %
    31.4
    Dividend yield 1yr %
    0

    Rubicon Research Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Rubicon Research Quarterly Revenue
    Sep 2025Jun 2025Sep 2024Jun 2024
    412.02 Cr
    352.49 Cr
    296.01 Cr
    316.72 Cr
    Rubicon Research Yearly Revenue
    Mar 2025Mar 2024Mar 2023
    1296.22 Cr
    872.39 Cr
    419 Cr
    Rubicon Research Quarterly Net Profit/Loss
    Sep 2025Jun 2025Sep 2024Jun 2024
    53.85 Cr
    43.3 Cr
    34.48 Cr
    25.56 Cr
    Rubicon Research Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023
    134.36 Cr
    91.01 Cr
    -16.89 Cr

    Rubicon Research Result Highlights

    • Rubicon Research Ltd reported a 15.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.

    • Its expenses for the quarter were up by 14.7% QoQ and - - YoY.

    • The net profit increased 24.4% QoQ and - - YoY.

    • The earnings per share (EPS) of Rubicon Research Ltd stood at 3.47 during Q2 FY 2025-26.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Rubicon Research Technical Analysis

    Moving Averages Analysis
    637.45
    Current Price
    Bullish Moving Averages
    0
    Bearish Moving Averages
    9
    Day EMA5
    647.40
    Day EMA10
    655.30
    Day EMA12
    656.20
    Day EMA20
    652.00
    Day EMA26
    643.80
    EMA
    EMA
    EMA
    Day SMA5
    647.40
    Day SMA10
    661.70
    Day SMA20
    661.90
    Day SMA30
    644.10
    SMA
    SMA
    SMA
    SMA
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    67352 Rs
    142454 Rs
    Week Rs
    100849 Rs
    225479 Rs
    Month Rs
    238541 Rs
    766421 Rs
    639.22
    Pivot
    Resistance
    First Resistance
    648.23
    Second Resistance
    659.02
    Third Resistance
    668.03
    Support
    First Support
    628.43
    Second support
    619.42
    Third Support
    608.63
    Relative Strength Index
    45.70
    Money Flow Index
    79.78
    MACD
    0.00
    MACD Signal
    0.00
    Average True Range
    29.31
    Average Directional Index
    22.56
    Rate of Change (21)
    3.12
    Rate of Change (125)
    0.00

    Name
    Holding Percent
    Kotak Midcap Fund
    1.86
    Motilal Oswal Special Opportunities Fund
    1.25
    Amansa Investments Ltd
    3.13

    Rubicon Research Latest News

    24 NOV 2025 | Monday

    Rubicon Research CEO Parag Sancheti Explains Strategic Bet On Nasal Spray Segment

    20 NOV 2025 | Thursday

    Rubicon Research Ltd - 544578 - Intimation For Updation Of Corporate Identification Number ("CIN") Of The Company

    18 NOV 2025 | Tuesday

    Rubicon Research Ltd - 544578 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    View More

    Rubicon Research Share Price FAQs

    Rubicon Research share price is ₹637.45 in NSE and ₹639.1 in BSE as on 2/12/2025.

    Rubicon Research share price in the past 1-year return was 0. The Rubicon Research share hit a 1-year low of Rs. 570.75 and a 1-year high of Rs. 754.8.

    The market cap of Rubicon Research is Rs. 10502.01 Cr. as of 2/12/2025.

    The PE ratios of Rubicon Research is 62.84 as of 2/12/2025.

    The PB ratios of Rubicon Research is 8.98 as of 2/12/2025

    The Mutual Fund Shareholding in Rubicon Research was 5.63% at the end of 2/12/2025.

    You can easily buy Rubicon Research shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Rubicon Research share price is ₹754.8 and ₹570.75 as of 2/12/2025.

    The earnings per share (EPS) of Rubicon Research stood at 3.47 during Q2 FY 2025-26.

    Please be aware that Rubicon Research stock prices are subject to continuous fluctuations due to various factors.

    Invest in Rubicon Research
    +91 -

    Popular Stocks
    317.90
    -3.75 (-1.17%)
    167.78
    -0.85 (-0.50%)
    300.55
    -0.95 (-0.32%)
    413.05
    -4.20 (-1.01%)
    388.45
    -1.30 (-0.33%)
    Top Gainers
    2,954.40
    +86.80 (+3.03%)
    1,275.20
    +15.10 (+1.20%)
    16,239.00
    +142.00 (+0.88%)
    2,104.00
    +14.30 (+0.68%)
    2,477.80
    +13.30 (+0.54%)
    Top Losers
    5,697.50
    -96.50 (-1.67%)
    1,258.00
    -17.70 (-1.39%)
    1,546.30
    -19.80 (-1.26%)
    1,373.00
    -17.10 (-1.23%)
    989.80
    -12.30 (-1.23%)
    Invest in Rubicon Research
    +91 -